| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.019 | 0.9 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.011 | 1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0029 | 1 |